Cibc World Market Inc. Amarin Corp Plcuk Transaction History

Cibc World Market Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $70,946 - $113,426	-21,897 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.94 - $5.84 $86,274 - $127,878	21,897 New	21,897 $112,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $257,276 - $1.38 Million	-64,319 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$13.94 - $24.12 $1.09 Million - $1.89 Million	-78,366 Reduced 54.92%	64,319 $1.38 Million
Q3 2019 Nov 13, 2019	BUY	$13.89 - $23.16 $2,472 - $4,122	178 Added 0.12%	142,685 $2.16 Million
Q2 2019 Aug 08, 2019	SELL	$16.27 - $20.51 $6,638 - $8,368	-408 Reduced 0.29%	142,507 $2.76 Million
Q1 2019 May 09, 2019	BUY	$12.61 - $22.33 $325,514 - $576,426	25,814 Added 22.04%	142,915 $2.97 Million
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $1.45 Million - $2.69 Million	117,101 New	117,101 $1.59 Million

3.55M

36.9K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $6.59B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.